Marlene L Cohen

Title: Marlene L. Cohen: Innovator in Serotonin Receptor Research

Introduction: Marlene L. Cohen, based in Carmel, IN, is a prominent inventor with an impressive portfolio of 28 patents. Her work primarily focuses on the development of compounds that interact with the serotonin receptor 5-HT4, contributing to advancements in therapeutic methods for various disorders.

Latest Patents: Among her latest inventions, Cohen has designed compounds of formula I that act as antagonists and partial agonists for the serotonin receptor 5-HT4. These compounds provide significant therapeutic methods for treating disorders caused by or affected by dysfunction of the 5-HT4 receptor. The dual action of these compounds makes them valuable assets in the field of neuroscience and pharmacology.

Career Highlights: Marlene L. Cohen has established her career at Eli Lilly and Company, a renowned pharmaceutical company. Throughout her tenure, she has made significant contributions to research and development, particularly in the area of serotonin receptors, leading to her extensive patent portfolio.

Collaborations: Cohen has collaborated with distinguished colleagues, including David W. Robertson and John M. Schaus. These collaborations have helped enhance the depth and breadth of her research, fostering innovation and progress in the field.

Conclusion: Marlene L. Cohen's innovative work on 5-HT4 receptor compounds has positioned her as a key figure in the realm of therapeutic inventions. Her continuous efforts in research and collaboration with other experts underscore her commitment to progressing the field of medicine, ultimately benefiting those affected by related disorders.